nasdaq lnth - Search News

Lantheus Holdings, NASDAQ and Q4

Lantheus’s (NASDAQ:LNTH) Q4 Sales Top Estimates, Stock Soars

Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) reported Q4 CY2024 results , with sales up 10.5% year on year to $391.1 million. On the other hand, the company’s full-year revenue guidance of $1.

Insider Monkey on MSN · 9h

Lantheus Holdings, Inc. (NASDAQ:LNTH) Q4 2024 Earnings Call Transcript

Q4 2024 Earnings Call Transcript February 26, 2025 Operator: Good morning. Welcome to the Lantheus Fourth Quarter and Full Year 2024 Conference Call. [Operator Instructions]. This call is being recorded and a replay will be available in the Investors section of the company’s website approximately two hours after the completion of

YAHOO!Finance · 2d

Investors in Lantheus Holdings (NASDAQ:LNTH) have seen incredible returns of 406% over the past five years

Lantheus Holdings, Inc. ( NASDAQ:LNTH ) shareholders have seen the share price descend 19% over the month. But

StockStory.org on MSN1d

Lantheus (LNTH) Shares Skyrocket, What You Need To Know

What Happened? Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) jumped 19.8% in the morning session ...

6hon MSN

Lantheus' Pylarify Hit $1B in 2024 Sales

Lantheus Holdings (NASDAQ: LNTH) held its fourth-quarter and full-year 2024 earnings call on Feb. 26, 2025, highlighting achievements in its radiopharmaceutical portfolio and announcing strategic ...

What Happened?

Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) jumped 19.8% in the morning session after the company ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Lantheus Holdings, NASDAQ and Q4

Trending now

Related topics